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Cis.diamminedichlorplatinum-induced acute renal failure in the rat.
Our micropuncture studies examined the pathophysiology of the main-
tenance phase of cis-diamminedichlorplatinum induced (CP) acute renal
failure (ARF) in rats. Nonoliguric ARF developed in 75% of the rats 96
hr after CP, 10 mg/kg i.p. Whole animal glomerular filtration rate (GFR)
decreased by 88% from control; micropuncture studies of superficial
proximal single nephron GFR (SNGFR) indicated a reduction of only
38% 96 hr after CP. A significant tubular fluid "backleak" of 3H-inulin
was demonstrated beyond the sites of micropuncture, resulting in the
disproportionate suppression of SNGFR as compared to GFR. The
morphologic basis for the failure of lissamine green to appear in distal
tubules, after an iv. or proximal intratubular injection, and for the
demonstration of 'backleak" appears to be C P-induced cell injury and
necrosis in the P3 segment of the proximal tubule. Loss of brush border,
swollen endoplasmic reticulum, loss of intercellularjunctional complex-
es, and epithelial cell sloughing into the tubular lumen were observed.
Light and electronmicroscopic examination failed to demonstrate any
abnormalities in P1 and P2 segments of proximal tubules in 7 of 9
animals. The remaining two animals had limited involvement of distal
P2 segments. The increase in superficial proximal tubule fluid to plasma
inulin concentration ratio (2.56 0.1, as compared to 1.78 0.09 in
control; P < 0.001) in association with a decreased tubule flow rate after
CP, suggests that these nephron segments, corresponding to P1 and P2
of morphologic studies, were physiologically intact. Comparable
SNGFR obtained in early and late superficial nephron segments is also
evidence against significant "backleak" in these segments. Although
intratubular casts were observed in morphologic studies, intratubular
hydrostatic pressure (IP) after CP was not different from control values.
Intravascular volume depletion resulting from a urinary concentrating
defect and decreased fluid intake was also present 96 hr after CP. Acute
volume expansion with 5% Ringer's solution, adequate to return the
packed red blood cell volume of the post-CP group (53 1.8%) toward
control values (48.8 1.9%), failed to significantly increase superficial
SNGFR, although whole animal GFR increased from 12 to 23% of
control values. CP-induced ARF in the maintenance phase has a
multifactorial pathogenesis. Tubular fluid "backleak" and a primary
decrease in glomerular filtration contribute to the decrease in GFR. The
possible role of intratubular obstruction cannot be excluded. Volume
expansion may more significantly affect deep nephrons after CP than
superficial nephrons.
L'insuffisance rénale aigue déterminée chez le rat par le cis-diammine.
dichioreplatine. Notre travail étudie par microponction Ia physio-
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pathologic de Ia phase de maintien de l'insuffisance rénale aigue (ARF)
déterminée par Ic cis-diamminedichloreplatine (CP). Une insuffisance
rénale aigue non anurique s'est développee chez 75% des rats 96 h après
CP, 10 mg/kg, i.p. Le debit de filtration glomerulaire du rein entier est
diminué de 88% par rapport aux contrôles; Ia mesure des debits de
filtration glomerulaire des néphrons individuels par microponction des
tubes proximaux indique une reduction de seulement 38% 96 h aprCs
CP. Met en evidence une fuite tubulaire significative de 3H-inuline au-
delà des sites de microponction. Cette fuite explique Ia discordance
entre SNGFR et GFR. Les bases morphologiques qui expliquent
l'absence d'apparition du vert de lissamine dans les tubes distaux après
injection intraveineuse ou intratubulaire proximale et qui explique Ia
fuite tubulaire paraissent étre des lesions des cellules déterminées par
CP et Ia ndcrose du segment P1 du tube proximal. La perte de Ia bordure
en brosse, Ic gonflement du reticulum endoplasmique, La perte des
complexes jonctionnels intercellulaires et Ic détachement de cellules
épithéliales dans Ia lumière tubulaire ont etC observes. L'examen en
microscopic optique et electronique n'a pas permis de mettre en
evidence d'anomalies dans les segments P1 et P2 des tubes proximaux
chez 7 des 9 animaux. Chez les deux autres animaux il a etC observe des
lCsions limitées de Ia partie distale des segments P2. L'augmentation du
rapport de Ia concentration de l'inuline plasmatique sur Ia concentration
de I'inuline dans Ic fluide tubulaire proximal (2,56 0,1 au lieu de 1,78
0,09 chez les controles; P < 0,001) associée a une diminution du debit
tubulaire apres CP, suggCre que les segments de néphron qui correspon-
dent a p1 et P2 dans les etudes morphologiques sont physiologiquement
intacts. La similitude des SNGFR mesurés dans les segments précoces
et tardifs du tube proximal est aussi un argument contre une fuite
significative dans ces segments. Bien que des cylindres intratubulaires
aient etc observes dans les etudes morphologiques, Ia pression hydro-
statique intratubulaire après CP n'est pas différente des valeurs con-
trôles. La depletion du volume intravasculaire consecutive a un deficit
de concentration urinaire et a une diminution de l'ingestion d'eau a etC
observée 96 h après CP. L'expansion aigue du volume au moyen d'une
solution de Ringer 5%, de telle sorte que l'hématocrite dans Ic groupe
post CP soit proche des valeurs normales (53 1,8% au lieu de 48,8
1,9%), n'a pas entrainé d'augmentation significative de SNGFR alors
que Ic GFR a augmenté de 12 a 23% des valeurs contrôles. L'insuffi-
sance rénale aigué consecutive a CF au cours de sa phase de maintien a
une pathogenic multifactorielle. La fuite tubulaire et une diminution
primaire du debit de filtration glomérulaire contribuent a Ia diminution
du debit de filtration glomCrulaire global. Un role possible de l'obstruc-
tion intratubulaire ne peut pas être éliminé. L'expansion du volume
peut affecter de facon plus importante, après CP, les néphrons profonds
que les nephrons superficiels.
Various coordination complexes of platinum have been
shown to have anti-neoplastic properties [1—6]. At present, cis-
diamminedichlorplatinum (CP) is the only such compound
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available for clinical use. In experimental and clinical studies,
CP has been found to have adverse effects on renal function [7—
16]. This nephrotoxicity is the most significant dose-limiting
factor in its clinical use [7—10]. Though animal experiments
examining the course of CP-induced acute renal failure (ARF)
have been performed [9, 12, 17], no detailed studies specifically
focusing on the pathophysiology are available. The present
study was undertaken to establish a model of CP-induced ARF
for detailed investigation of its pathophysiologic mechanisms
using micropuncture techniques. Because initial experiments
indicated alterations consistent with volume depletion after CP,
additional studies to evaluate the effect of volume expansion
(VE) in this model of ARF were also performed.
Methods
Pilot study. Eighteen male Sprague-Dawley rats (250 to 350 g)
were used for this study. Three groups of 6 rats each were
injected i.p. with a single dose of CP, 2.5 mg/kg of body wt
(group A); 5 mg/kg of body wt (group B); or, 10 mg/kg of body
wt (group C). The animals were maintained on tap water and
regular rat food before and after the CP injection. Free-flowing,
tail vein blood was collected from each rat daily for blood urea
nitrogen (BUN) determinations by the conductivity rate method
(Beckman Instruments, Fullerton, California). In group A,
BUN remained unchanged at 96 hr after CP (Table 1). Groups B
and C developed dose-related rises in BUN at the same time
interval after CP. On the basis of these preliminary data, studies
were performed using CP at a dose of 10mg/kg of body wt, i.p.
Cage studies. Twenty-two Sprague-Dawley rats (250 to 350 g)
were maintained in metabolic cages (Hazelton Systems, Cleve-
land, Ohio) on regular rat food and unlimited access to tap
water, After 2 days of acclimation to the cages, metabolic
studies were started. Sixteen rats were injected with CP, 10 mg/
kg of body wt, i.p., and 6 rats had sham injections using diluent
only (1% mannitol in isotonic sodium chloride solution). Study
periods for both groups were divided into preinjection periods,
lasting up to 3 days, and postinjection periods, lasting up to 9
days. During both periods rats were weighed daily, and 24-hr
water intakes and urine outputs were measured. Free-flowing,
tail vein blood (approximately 200 p.l) were obtained from each
rat daily. Creatinine concentrations in serum and urine were
measured by the Jaffe technique (Beckman Instruments, Fuller-
ton, California), and serum and urine samples were analyzed for
sodium by flame photometry (Instrumentation Laboratories,
Lexington, Massachusetts). Urine osmolality was measured by
freezing point depression (Advance Instruments, Needham,
Massachusetts). Urine flow rates (V), creatinine clearances
(Car), and fractional excretion of sodium (FENA) were calculat-
ed using standard formulas.
Micropuncture studies. Micropuncture studies were per-
formed on male, Sprague-Dawley rats (220 to 370 g), maintained
on regular rat food and tap water. Studies were performed in 3
groups: group 1, control (N = 20); group 2, experimental rats
studied 96 hr after CP, 10 mg/kg of body wt, i.p. (N = 10); group
3, 96 hr after CP, 10 mg/kg of body wt i.p. before and after acute
volume expansion (yE); (N = 6). On the day of micropuncture
studies, 200 p.l of free-flowing, tail vein blood was collected to
measure serum creatinine concentration. All the groups 2 and 3
animals studied had serum creatinines > 0.6 mg/dl. Animals
were anesthetized with pentobarbital, 60 mg/kg i.p., and placed
Table 1. Pilot study: BUN concentration before and 96 hr after CP"
Group A Group B Group C
CP 2.5 mg/kg CP 5 mg/kg of CP /0 mg/kg of
of body it i.p. body WI body wi ip.N=6b N=6 N=6
Preinjection 19.5 2.6 16.8 1.1 22.3 5.18
96 hr post-CP 18.5 4.5 57.8 12.6° 128 47.2cd
a All values are mean SEM.
b N represents the number of rats studied in each group.
Significantly different (P < 0.05) from preinjection vaIues or
group B.°
Abbreviations: BUN, blood urea nitrogen concentration (mg/dl); CP,
cis-diamminedichlorplatinum.
on a thermoregulated table designed to maintain rectal tempera-
ture at 38° C. A tracheostomy catheter (PE 240) was inserted.
Jugular and femoral veins were catheterized (PE 50) to adminis-
ter additional anesthesia and intravenous fluid (Ringer's solu-
tion at 1.2 ml/hr), respectively. A catheter (PE 50) was placed in
the left femoral artery to monitor systemic BP, and a suprapu-
bic bladder catheter (PE 90) was inserted, The left kidney was
exposed by a subcostal incision, freed from the perirenal fat and
adrenal gland, and then placed in a Lucite® cup. The surface of
the kidney was bathed continuously with warm mineral oil
(38° C). Lissamine green, 60 p.1 of 5% in Ringer's solution, i.v.,
was injected for measurement of proximal and distal tubule
transit times, as described previously. These measurements
were performed to evaluate semi-quantitatively the tubular flow
rates. Then 0.5 ml '4C-inulin in Ringer's solution (50 p.Ci/ml)
was given i.v. and an infusion of the same solution started at 1.2
ml/hr. Only rats having a mean arterial BP greater than 95 mm
Hg were included in the studies.
Groups I and 2. After a 45-mm inulin equilibration period,
micropuncture experiments were started. Superficial proximal
tubules were punctured with glass pipettes (OD 8 to 12 p.) filled
with Sudan® black-stained mineral oil. After injecting an oil-
block distal to the tip of the pipette (about 3 to S tubule
diameters long), tubule fluid was collected for approximately 1
to 2 mm in control animals and for up to 4 mm in experimental
rats. Tubule fluid samples were transferred to a precalibrated,
constant-bore, capillary tube to measure their volume and then
placed in liquid scintillation vials containing 0.6 ml of distilled
water and 7.0 ml of Biofluor® (New England Nuclear, Boston,
Massachusetts). Multiple-timed urine collections were made
under oil from the bladder catheter. Free-flowing, tail vein
blood was collected in heparinized, capillary tubes approxi-
mately every 20 mm. Aliquots of urine and blood (2 p.l) were
placed into liquid scintillation vials containing distilled water
and Biofluor®. '4C-inulin was measured in tubule fluid (TF),
urine (U), and plasma (P), using a liquid scintillation counter
(Packard Instrument Co., Downers Grove, Illinois). Tubule
fluid flow rate (v) and urine flow rate (V) were calculated.
Whole animal glomerular filtration rate (GFR) and single neph-
ron filtration rates (SNGFR) were calculated using standard
formulas.
Group 3. Micropuncture studies were performed on this
group of rats before and after volume expansion. Rats were
prepared and micropuncture studies were carried out as de-
scribed above (pre-VE period, 3A). The rats were then volume
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expanded with Ringer's solution (5% of body wt, i.v.) over 30
mm, and additional '4C-inulin administered to maintain a con-
stant plasma concentration. Rats were allowed to equilibrate to
VE for 45 miii and then micropuncture studies were carried out
again (post-VE period, 3B). After YE, the infusion rate of
Ringer's solution was adjusted to compensate for the enhanced
urine volume.
In addition to random measurements of superficial proximal
SNGFR, early and late superficial proximal SNGFR measure-
ments were carried out in group 3B rats. Using a micropipette
(OD 2 to 5 i) containing 0.5% lissamine green in Ringer's
solution, a superficial loop was punctured. The nephron's
course was delineated with an intratubular injection of lissa-
mine green. Subsequently, timed tubular fluid collections were
made, as noted above, from the last accessible segments of the
proximal tubule (late and/or from the most proximal segments
of superficial, proximal tubules, early). Multiple determinations
of packed cell volume were made using tail vein blood before
and after YE. Results are presented as the mean of these
determinations.
Microinjection studies. To evaluate the possibility of tubular
fluid backleak, we injected 3H-inulin in proximal tubules of the
left kidney, and its excretion was measured from both the left
and right kidneys separately. Measured recovery of 3H-inulin
from the right kidney was interpreted as evidence for tubular
fluid back-leak. These experiments were performed in control
rats and in a separate group of experimental rats 96 hr after CP,
10mg/kg of body wt, i.p., in the hydropenic state. Selection and
preparation of animals were the same as in the micropuncture
studies (groups 2 and 3), except that all the animals had a
bladder catheter and a left ureteral catheter (PE 10) to allow
separate collections of urine from the left and the right kidneys.
Radioactive inulin was not infused.
Lissamine green-stained 3H-inulin solution was aspirated into
a constriction glass pipet having an approximate volume of 20
ni. Multiple samples were deposited under oil in a petri dish and
later aspirated into the tips of glass pipets (OD, 6 to 8 ii) filled
with stained mineral oil. Some of these samples were trans-
ferred into liquid scintillation vials containing water and Bio-
fluor® to calculate the amount of radioisotope microinjected.
3H-inulin was slowly injected over a 5-to-lO mm interval into
a superficial proximal tubule with efforts made to avoid any spill
or leak of the fluid, retrograde perfusion of the tubule, injection
of any oil into the tubule, or any change in tubular diameter.
Only injections fulfilling these requirements were considered
acceptable for interpretation, both in the control and experi-
mental rats. After injection, urine samples form both left and
right kidneys were collected separately into vials for 60 mm.
Results were expressed as a percentage recovery of 3H-inulin
from each side.
Intratubular pressure measurements. Proximal intratubular
hydrostatic pressures were measured in both the control and
CP-injected rats using glass pipettes (OD 2 to 5 p.) filled with 1 M
sodium chloride and a servonulling pressure device [17]. Tu-
bules were chosen randomly for the pressure measurements.
Statistical analyses were performed by unpaired and paired
Student's I test, where appropriate. A value of P < 0.05 was
considered statistically significant. All values are expressed as
mean SEM.
Morphologic studies. Nineteen male Sprague-Dawley rats
(240 to 325 g) were used for this study. Thirteen rats were
injected with CP (10 mg/kg of body wt, i.p.), and 6 control rats
received injections of diluent only. Ninety-six hours following
the administration of CP, the animals were anesthetized with
pentobarbitol (50 mg/kg, i.p.), and blood was collected for the
determination of serum creatinine concentration. The kidneys
were fixed by vascular perfusion with 2% formaldehyde to 1%
glutaraldehyde in a 200 mOsm phosphate buffer, removed,
bisected, and placed in the fixative solution until further proc-
essing, as previously described [201. Small rectangular slices of
tissue, extending from the capsular surface to the inner stripe of
the outer medulla, were trimmed, rinsed overnight in 0.2 M
sucrose to 0.1 M cacodylate buffer postfixed with 1% 0s04 ins-
collidine buffer for 1 hr, and stained overnight en bloc with
uranyl acetate. The tissue was dehydrated in a graded series of
alcohols, infiltrated with propylene oxide, and flat embedded in
Poly/Bed 812 media.
Semi-thin (0.5 p.) plastic sections were cut and stained with
toluidine blue. Areas were selected for further trimming and
thin sectioning so that from each animal areas of the outer and
inner cortex, medullary rays, and outer stripe of the outer
medulla were sampled. Sections were mounted on copper grids
and stained with uranyl magnesium acetate and lead citrate.
Tissue sections were examined and photographed with a JEOL
100 B electron microscope. In addition, a portion of each
kidney was processed for light microscopy. Paraffin sections
were cut and stained with hematoxylin and eosin (H&E) and
periodic acid-Schiff (PAS) reagent.
The nomenclature used for the different segments of the
proximal tubule follows the scheme of Jacobsen and Jorgensen
[21], based on the observations of Maunsbach [22].
Results
Cage studies. The results from the cage studies are presented
in Figure 1. Of the 16 rats, 4 failed to develop renal failure; the
results of those 4 are not included in Figure 1. The remaining 12
rats had serum creatinine concentrations greater than 0.6 mg/dl
96 hr after CP. The first significant increase in serum creatinine
concentration occurred 72 hr post-CP. At 96 hr as indicated in
Figure 1, renal failure was well established, and the rats were
considered to be in the maintenance phase of ARF. The peak
serum creatinine concentration occurred 6 days after CP. This
was followed by a rapid decline in serum creatinine concentra-
tion over the ensuing 4 days, characteristic of the recovery
phase of ARF. During the interval from the fourth through the
eighth day after CP, 8 of the 12 rats died, but only 1 died on the
fourth day after CP. Thus, on the fourth day after CP, 75% of
the rats had developed ARF with a minimum mortality. Micro-
puncture studies, therefore, were performed 96 hr after CP to
examine the pathophysiology of the maintenance phase of CP-
ARF,
Detailed results of the metabolic studies in the preinjection
period and on the fourth day after CP are summarized in Table
2. There was a significant decrease in body weight after CP, as a
result of decreased fluid intake and well maintained urine
output. Higher packed cell volumes following CP are additional
evidence of intravascular volume depletion. The mean urine
flow rate after CP was not significantly different from that
observed in the preinjection period. Maintenance of a normal
urine volume after CP was not a consistent finding, Three of the
11 rats were oliguric (urine output less than 2.0 ml per 24 hr per
100 g of body wt) on day 4. The fractional excretion of sodium
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(FENA) was significantly higher after CP (2.71 0.94%), as
compared to the pre-CP injection value of 0.59 0.002% (P <
0.025). Endogenous Cr decreased to 0.27 0.12 ml/min in the
interval following CP. It is recognized that endogenous CCr in
the CP group may underestimate GFR because of the non-
steady state conditions. The values, however, are comparable
to those observed for inulin clearances obtained during micro-
puncture studies (Table 3). The sham injections of diluent in 6
rats failed to cause any change in the renal function at any time
interval after the injection. All the parameters studied remained
unchanged and were not statistically different from either the
control rats in our laboratory or the preinjection CP group.
Micropuncture studies, Group 1 (control), 2 (post-CP). Nine-
ty-six hours after CP, mean body weight loss in the experimen-
tal group was 44.3 7.7 g paralleling the cage study data.
Packed cell volume in the experimental group was significantly
greater than the control value (P < 0.005). These alterations in
body weight and packed cell volume support the presence of
intravascular volume depletion. At the time of micropuncture
the kidney surface in the post-CP rats appeared homogenous.
Mild and uniform dilatation of the tubules was observed,
without evidence of intratubular cellular debris. During the
micropuncture studies, tubules were found not to be friable or
"ballooned."
Proximal tubular transit times were 39.2 4.5 sec in the
experimental group, as compared to 11.0 0.8 sec in controls
(P < 0.02). Lissamine green never appeared in the distal tubules
of experimental rats even after observation periods of up to 45
mm following either intravenous or proximal intratubular injec-
tion. No leak or transtubular extravasation of the lissamine
green was observed in any of the tubules. Because of inability
to identify distal tubules, distal micropuncture studies could not
be performed. The micropuncture data are summarized in Table
4,
GFR, V, U/P inulin (Table 3). The total GFR. as estimated
from inulin clearance, was 0.09 0.03 ml/min/l00 g of body wt
in the experimental group, a value significantly (P < 0.001)
lower than that of 0.83 0.05 ml/min/l00 g of body wt in the
control group. CP caused a marked reduction (P < 0.001) in U/P
inulin ratios and increased urine flow (P < 0.05) in group 2
animals, as compared to control studies. The U/P inulin ratios
and increased urine flow rates, when compared to the control
rats, are consistent with an observed CP-induced concentrating
defect, similar to that apparent in cage studies (nonoliguric
ARF).
SNGFR, v, TF/P (Table 4). In group 2, CP resulted in
decreased SNGFR and tubular fluid flow rates (v). TF/P ratios
were 1.78 0.09 and 2.56 0.10 in groups I and 2, respectively
(P < 0.001). As noted above, there is a urine concentrating
defect in CP-induced ARF. Therefore, the decreased superficial
SNGFR may be due to volume depletion (as suggested by the
observed changes in TF/P-In and v). To evaluate the role of
volume depletion in CP-induced ARF, group 3 studies were
performed.
Groups 3A and 3B (post-CP, before and after volume expan-
sion). Prior to volume expansion, rats in groups 2 and 3 had a
similar degree of renal impairment and changes indicative of
volume depletion (Table 3). Comparison of the data between
before (3A) and after (3B) volume expansion are summarized in
Tables 3 and 4. VE resulted in a decrease in packed cell volume
to a value comparable to that observed in group I. Total GFR
increased from 0.10 0.01 ml/min/lOO g of body wt to 0.19
0.02 ml/min/l00 g of body wt (P < 0.025) after yE. U/P inulin
ratios remained essentially unchanged and urine flow rate (V)
increased markedly after VE (P < 0.05). SNGFR before volume
expansion (3A) was 6.12 0.43 nl/min/100 g of body wt, and
volume expansion failed to significantly increase the SNGFR.
Tubular fluid flow rate (v) and TF/P inulin ratio also failed to
change significantly with volume expansion.
Early, superficial proximal SNGFR was 7.92 1.26 nI/mini
100 g of body wt (N = 15), a value not significantly different
from late superficial proximal SNGFR of 7.04 0.9 nl/min/lOO
g of body wt (N = 17) (P <0.5). These data include values from
13 paired early and late superficial proximal SNGFRs.
To evaluate the degree of variance in the distribution of
SNGFR, data from group 2 were compared with that of control
using the coefficient of variation method [23]. Standard devi-
ation (SD), expressed as a percentage of mean SNGFR in each
animal, was calculated, The SD was 39 5% of mean SNGFR in
group 2, as compared to 15 2% in group 1 (P < 0.001),
signifying a greater degree of heterogeneity in the SNGFR
values at 96 hr post-CP. In group 3, pre-VE SD was 30 8% of
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Fig. 1. Serum creatinine concentration in
post-CP and control groups. Asterisk (*)
denotes significantly different values as
compared to control (P < 0.05). Numbers
of surviving rats are in parentheses.
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Table 2. Metabolic cage studies: Renal function before and on fourth day after CP, 10 mg/kg of body wt i.p.a
All values are mean SEM.
N represents the number of rats studied.
Significantly different (P < 0.05) from preinjection values.
Abbreviations: V, urine flow rate; FEN,,, fractional excretion of sodium: CP, cis-diamminedichlorplatinum; U/F, urine/plasma.
Table 3. Micropuncture studies 96 hr after CP,10 mg/kg of body wt: Whole animal data
Group
Packed cell volume
%
GFR
rnI/,nin/100 g of body itt U/P inulin
V
1jJ/,nin/IOO g of body wi
Serum creatinine
ing/di
Control 49.0 0.83 488 1,84 0.4
N = 20b 1.0 36.0
2
96 hr post-CP 55.0c 0.09k l9.9 3.60c l.8
N = 10 2.0 4.13
3A
96 hr post-CP 53.0c 0.10 38.8 2.69w l.7c
Pre-VE, N = 6 1.8 2.73
3B 48.8d 0.l9 35.9 7.l3d
Post-VE 1.9 6.63
a All values are mean SEM.
h N represents the number of rats studied in each group.
dSignificantly different (P < 0.05) from group Ic and group 2 and group 3A.'
Abbreviations: V, urine flow rate; U/P. urine/plasma; Cr, creatinine; VE, volume expansion, that is, Ringer's solution 5% of body wt; CP, cis-
diamminedichlorplatinum.
Table 4. Micropuncture studies 96 hr after CP,I0 mg/kg of body wt: Single nephron function
Group
SNGFR
nl/min/100 g of body wi
v
n//inin/IOO g of body wi TF/P inulin
Control 10.56 0.47 6.5 0.39 1.78 0.09
N = 20 (42)c
2
96 hr post-CP 6.55 0.43d 2.84 0.2I 2.56 0.lOd
N=10 (96)
3A
96 hr post-CP 6.12 0.43a 3.11 0.73" 2.39 0.23d
Fre-VE (15)
N=6
3B 6.95 0.85d 3.39 1.09 2.40 0.79d
Post-VE (14)
a All values are mean SEM.
N represents the number of rats studied in each group.
Numbers in the parenthesis are the numbers of observations.
ci Statistically different (P < 0.05) from control.
Abbreviations: SNGFR, single nephron glomerular filtration rate; v, tubular fluid (TF) flow rate; yE, volume expansion, that is, Ringer's
solution, 5% of body wt.
mean SNGFR, not statistically different from post-VE (32
6%, P <0.3 NS). VE did not affect the degree of heterogeneity
suggesting that the same population of nephrons were sampled
in the pre- and post-VE periods.
Intratubular hydrostatic pressures and microinjection stud-
ies. Intratubular hydrostatic pressure of superficial proximal
tubules in the CP-treated group was 14.0 0.8 mm Hg (140
observations in 7 rats), a value not different significantly from
that of 14.1 1.0 mm Hg in the control group (43 observations
in 7 rats). For comparison purposes the SNGFR results in rats
observed in groups I and 2 are also depicted in Figure 2.
Figure 3 illustrates the relative changes in GFR and SNGFR.
The decrease in SNGFR after CP was much less for a given
decrease in total GFR. To evaluate the possibility of a transepi-
thelial filtrate "leak," as a cause of the disproportionate
changes in SNGFR and total GFR, microinjection experiments
were performed. Recovery of 3H-inulin from microinjections in
6 control rats were 97.6 1.1% from the ipsilateral side, and 1.4
Wt
Packed cell
volume
Serum
creatinine V U/P
g % mg/d/ p//mi,, creatinine
Creatinine
clearance
mn//mm
Pre-CP 294 46.54 0.35 11.38 203 2.28 1722
N= 12b 6 0.44 0.69 12.0 113
Four days
afterCP
265c
11
53.36c
1.28
1.7fr 8.15
2.52
24.Oc
9.6
0,27c 834c
112
Urine
osmolality
mOsm/kg
FENa
0.59
2.7 Ic
±0.94
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Control Post-CP Control Post-CP
SNGFR P
Fig. 2. Comparison of single nephron glomerular filtration rates(SNGFR) and proximal, intratubular hydrostatic pressure (IF) in
control and 96 hr post-CF rats. Values are mean SEM. A significant
(*) decrease (P < 0.05) in SNGFR in the post-CP group, as compared to
control group, was not accompanied by any change in IP.
0.2% from the right kidney (Fig. 4). In contrast, 13 microin-
jections in 8 CP-injected rats demonstrated a markedly reduced
3H-inulin recovery from the ipsilateral kidney of 26.3 6.4%.
and increased recovery from the right kidney of 13.9 3.4%, as
compared to the control group (P < 0.001 and P < 0.005,
respectively). Total recovery was also significantly decreased
to 40.2 9.1%, as compared with 98.9 1.0% in the control
group (P < 0.005). These data are consistent with the transepi-
thelial back-diffusion of glomerular filtrate. All the tubules
studied in each CP rat demonstrated this marked "leak" of
radiolabelled inulin, indicating that each rat developed a defect
in tubular integrity at this stage of ARF (Fig. 4). Only 2 of the 8
CP-injected animals reported in Figure 4 had comparatively
higher total recoveries of 3H-inulin and lesser degrees of tubular
leak, suggesting some variation in the severity of renal failure
secondary to CP.
Morphologic studies. The renal morphology of control ani-
mals, by light and electron microscopy, was in agreement with
previous descriptions [22, 24]. Three of the 13 CP-treated
animals failed to develop kidney failure. The morphology of the
kidneys from these animals was indistinguishable from control.
Ten of the CP-treated animals (77%) developed kidney failure,
that is, serum creatinine > 0.6 mg/dl; one of these animals died
prior to sacrifice and was not included in the study.
Fig. 3. Comparison of glomerular filtration rate (GFR) and single
nephron (SN) GFR between group 1 (Control), group 3A (pre-VE) and
group 3B (Post-VE). Mean results are presented as percent of control
values. Both GFR and SNGFR in 3A and 3B were significantly different
(P < 0.05) as compared to control; but only GFR in 3B is significantly
different (P < 0.05) from that of 3A.
Morphological examination of the kidneys of the CP-treated
animals in kidney failure revealed widespread cell injury and
necrosis of the P3 segment of the proximal tubule located in the
outer stripe of the outer medulla (Figs. 5 and 6). This was
accompanied by a variable degree of involvement of that
portion of the P3 segment which traverses the medullary ray
extending toward the capsular surface. The injured tubular cells
gathered and desquamated into the tubular lumen. Occasional-
ly, foamy casts, composed of cell debris, were seen filling the
lumen of the proximal tubules at the junction of the outer and
inner stripe of the outer medulla. Basophilic regenerative cells
were seen in many of the tubules which contained necrotic
cells.
From electron microscopy observations, we found the char-
acteristics of the injured P3 cells included a loss or thinning of
the cell brush border, breakdown of cytoplasmic polysomes,
swollen as well as aggregates of smooth endoplasmic reticulum.
condensed or swollen mitochondria, nucleolar segregation.
dispersed heterochromatin, and a loss of junctional complexes
with neighboring cells. The tubular cells sloughing into the
lumen were found to include not only necrotic cells, with
disrupted membranes and swollen mitochondria filled with
flocculent densities, but also cells with a dense cytoplasm
containing condensed mitochondria, revealing characteristics
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associated with sublethal cell injury. These latter cells appeared
to be lifted off the basal lamina by flattened regenerative cells.
Despite the presence of this relining epithelia, areas of denuded,
basal lamina were apparent (Fig. 6b).
In sharp contrast to the severely damaged P3 segment, the
proximal-convoluted tubule, which includes the P1 and the
majority of the P2 segment, was indistinguishable from control
by both light (Fig. 5) and electron microscopy (Fig. 7), except in
two animals where necrosis was found to involve part of the
proximal-convoluted tubule. The injured tubules were lined by
a low epithelium with a focal absence or thinning of the brush
border. Even in these animals, however, many of the tubular
cross sections, particularly those clustered around glomeruli,
maintained normal morphology. All of the P1 neck segments,
identified by their origin from Bowman's capsule, were normal
suggesting that the injury involved the more distal P2 segment of
the proximal-convoluted tubule.
The glomerular ultrastructure appeared to be normal in all
animals studied. The only consistent alterations observed in the
distal nephron were frequent PAS-positive casts and dilation of
the basolateral intercellular spaces of the collecting tubules.
Fig. 5. A Light micrograph of control kidney (x60). B Lightmicrograph
96 hr after CP administration (x60). The proximal convoluted tubules
located in the cortex of both control and CF-treated animals appear
normal. Following CP administration, however, the cells located in the
outer stripe of the outer medulla (OM) undergo necrosis (arrows). Distal
tubular casts (arrowhead) are also present in CP-treated animals. C
denotes the capsular surface. Obtained from paraffin-embedded tissue
stained with H & E.
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Fig. 4. 3H-inulin recovery from left and right kidneys after proximal
tubular microinjections in control and experimental groups (that is, rats
studied 96 hr post-CP 10 mg/kg of body wt, i.p.,i. The results are
expressed as % recovery of microinjected 3H-inulin. Both left- and
right-sided recoveries in the experimental group are significantly differ-
ent (P < 0.05) as compared to corresponding recoveries in the control
group.
C
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Fig. 6. Panel AElectron micrograph of a P3 segment from a control kidney. The long brush border (BB) and randomly-oriented mitochondria (M)
are characteristic of P3 cells (x9800). Panel B Electron micrograph of a P3 segment 96 hr after CP administration. The cell has gathered and lost
much of its normal cytoplasmic ultrastructure. Note the focal loss of the brush border (arrowhead), the condensed mitochondria (M) and the
denuded basal lamina (arrow), covered only by cell debris (x8580).
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Fig. 7. Electron micrograph qf a P2 segment 96 hr after CF administra-
tion (x8600). The ultrastructural appearance is indistinguishable from
control. The brush border (BB), lysosomes (L). and mitochondria (M)
appear normal. C denotes a capillary.
Discussion
The nephrotoxicity of coordination complexes of platinum
has been well established in animal and human studies [1—171.
The major route of platinum elimination from the body is
through urinary excretion [13, 17]. High concentrations of
platinum in renal tissue, after administration of CP to the
animals, have also been observed with various dosage regi-
mens, and renal function deterioration is dose dependent 17—10,
14—16], A chronic, repetitive, low dosage of CP in rats also
leads to kidney failure, creating a situation similar to kidney
insufficiency clinically observed during the prolonged chemo-
therapeutic regimens used for various malignancies [121.
Our studies were designed to observe the effects of acute,
single dose CP-administration on kidney function. These stud-
ies confirm the dose-related (Table 1) acute renal toxicity of CP
[7—10, 14—16] and its course (Fig. 1). Increases in serum
creatinine concentration were accompanied by urine flow rates
comparable to control period, diminished urine osmolality,
decreased U/P creatinine concentration ratios, and a significant
increase in the fractional excretion of sodium. The results
demonstrate that CP administration results in a non-oliguric
form of ARF.
The micropuncture studies 96 hr after CP 10 mg/kg demon-
strate the presence of significant kidney failure, as estimated
from inulin clearance. When suppression of whole kidney inulin
clearance and superficial single nephron inulin clearance oc-
curred, changes were disproportionate (Fig. 2). Whole animal
GFR decreased by 88% from control, while SNGFR was
reduced only by 38%. This pattern of change in superficial
nephron filtration and total glomerular filtration has been ob-
served in other models of acute kidney failure [23, 25]. The
disproportionate changes in GFR and SNGFR may be due to
significant transepithelial filtrate back diffusion beyond the site
of micropuncture. In our studies, the inability to visualize any
superficial distal tubules after intravenous and proximal-intra-
tubular, lissamine green injection is consistent with a significant
tubular fluid back-leak between the last superficial convolution
of the proximal tubule and the distal tubules. More specifically,
the microinjection data demonstrated incomplete collection of
intratubularly injected radiolabelled inulin on the site of injec-
tion, and contralateral excretion of inulin, indicating "back-
leak" of inulin beyond the sites of microinjection. Both the
phenomena of lissamine green "leak" and back diffusion of
microinjected, radioactive inulin have been demonstrated in
other kidney failure models [23, 25—32]. Transtubular diffusion
of inulin in these models has been considered as evidence for
the back-leak of glomerular filtrate [23, 25. 27]. In addition, a
morphologic basis for back-leak is provided in our study as
demonstrated by the presence of extensive necrosis involving
the P3 segment of the proximal tubule at 96 hr post-CP.
Intratubular pressure changes do not appear to be a cause of, or
a contributing factor to, the transtubular fluid back-leak in our
study because superficial, proximal, intratubular, and hydro-
static pressures were the same as that in control animals.
Although intratubular, hydrostatic pressures were not deter-
mined during the microinjection studies, standard and well
established microinjection techniques were utilized to insure a
minimization of artifact-related increases in intratubular pres-
sure during microinjection [23, 25, 27]. Moreover, microinjec-
tion studies were performed in non-diuretic animals to avoid the
problems associated with high-tubular, fluid-flow rate and the
associated increases in intratubular pressure accompanying the
diuretic state.
It is possible that superficial SNGFR was over-estimated,
relative to whole kidney GFR, due to "venting" of the obstruct-
ed nephrons. Because intratubular, hydrostatic pressures were
within the normal range in our study, significant intratubular
obstruction was not present. In addition, even when a relatively
minor degree of tubular obstruction seems to have been present
after CP, the release of higher intratubular, hydrostatic pres-
sures by "venting" may not necessarily lead to an over-
estimation of SNGFR [23]. It must be noted, however, that the
observation of a normal intratubular, hydrostatic pressure in
association with a reduced SNGFR and back-leak after CP does
not eliminate the possibility that intratubular obstruction is
present. With the use of both light and electron microscopy, the
morphologic studies performed reveal the presence of casts
containing cellular debris within tubular lumina at the junction
of the outer and inner medullary stripes. Observations favoring
the presence of intratubular obstruction have been made in
other models of ARF [18, 26—29, 34—36]. Also the incomplete
recovery of radiolabelled inulin during microinjection studies
has been interpreted as evidence of tubular obstruction in the
unilateral postischemic acute kidney failure model [251.
If one accepts an insignificant (if any) role for intratubular
obstruction and the presence of leak only at nephron sites distal
to those used to obtain proximal SNGFR determinations, then
two possible explanations remain for the observed discrepant
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changes in SNGFR and whole kidney GFR: Heterogeneity of
nephron dysfunction with a more severe decrease of SNGFR in
the deeper-juxtamedullary nephrons, as opposed to superficial
nephrons; or, internephron heterogeneity and associated sam-
pling error in animals after CP. Data are not available in our
study comparing superficial and juxtamedullary nephron func-
tions. Regarded as unlikely is the possibility of sampling error,
that is, obtaining punctures after CP only from the best func-
tioning nephrons. At the time of micropuncture after CP, all
nephrons had a similar appearance and random micropunctures
were performed. The observation that SNGFRs obtained in
animals post-CP had a greater coefficient of variation than the
control animals suggests a less uniform dispersion of nephron
function than in control and is consistent with previous obser-
vations in various experimental models of ARF. The greater
display of SNGFR values obtained after CP supports the
random nature of the micropunctures obtained in these rats in
the presence of heterogeneous nephron function.
Definite evidence of intravascular volume depletion was
present at the time of micropuncture studies, that is, increased
packed cell volumes and lower body weights as compared to
control animals. In addition to subnormal fluid intake in the
experimental group, presence of diarrhea, and persistently high
urine flow rates contribute to volume depletion. A severe
concentrating defect after CP administration was also observed.
The changes in the total GFR and SNGFR are not the result of
volume depletion alone, as might occur in nephrogenic diabetes
insipidus without intrinsic kidney failure because morphologic
evidence of acute, tubular necrosis and tubular fluid back-leak
establish a definite basis for intrinsic kidney disease secondary
to CP.
Acute volume expansion resulted in the return of packed cell
volumes toward control values. The resultant increase in urine
volume after VE demonstrated the persistent and severe con-
centrating defect. VE was associated with a modest but statisti-
cally significant increase in GFR (vs. 3A), although superficial
SNGFR, TF/P inulin ratios, and tubular fluid, flow rates failed
to change significantly. Thus, the decrease in superficial
SNGFR was not due to volume depletion and was not respon-
sive to volume expansion. The stable, superficial SNGFR after
VE cannot be ascribed to an increase in tubular fluid back-leak
compensating for any possible increase in the filtration rate at
the glomerulus because TF/P ratios remained unchanged in the
tubular segments where micropunctures were performed post-
yE. The slight increase in GFR may be ascribed to an effect of
VE on juxtamedullary nephrons, a factor not evaluated in this
study. Hemodynamic studies in other nephrotoxic, acute renal
failure models have demonstrated a preferential decrease in
outer cortical, renal blood flow with relatively well maintained
inner cortical, blood flow [18, 26, 27] supporting this postulate.
Although a trend towards increased fractional tubular fluid
reabsorption may be seen in the initiation phase of ARF [18], in
established ARF the TF/P inulin values are usually lower than
control values. In our study, during well established renal
failure, TF/P inulin in the proximal tubule increased, indicating
the increase of fractional, tubular, fluid reabsorption. This
finding may be explained by a decrease in tubular flow rates
(56%) and SNGFR (38%) in the presence of relatively intact
reabsorption mechanisms in the superficial, proximal tubules
up to the point of micropuncture. The relatively normal,
proximal tubule, reabsorptive capacity late in the course of
established, acute renal failure may also relate to selective
sparing of these segments from the nephrotoxic effects of CP or
the appearance of functional abnormalities in these segments
later in the course of renal failure, after the time of micropunc-
ture studies. This well preserved, tubular function stands in
contrast to the demonstration of tubular fluid leak, suggesting
heterogeneity of damage along the length of the nephron.
Furthermore, SNGFR measurements in early and late proximal
tubule segments are comparable, presenting evidence against
any signficant inulin or tubular, fluid back-leak in the punctura-
ble, superficial proximal nephron.
The heterogenous response of different segments of the
proximal tubule is further supported by the findings of the
morphologic study. The early segments of the proximal tubule
accessible to micropuncture were shown to maintain normal
morphology 96 hr following CP administration in all but 2
animals. Even in these animals, many normal tubules could be
found. This finding is in sharp contrast to the widespread cell
injury and necrosis observed in the P3 segment of the proximal
tubule which is inaccessible to micropuncture. These observa-
tions are consistent with previous reports of light [12, 141 and
electron microscopic [16] studies of CP-induced tubular dam-
age. It is of note in this respect that other ARF models are
associated with most marked structural changes in the pars
recta, beyond the site of micropuncture [34, 37J.
It would appear, therefore, that several mechanisms may be
operative in CP-induced ARF. Decreased superficial SNGFR in
intact tubule segments, proximal to the site of back-leak, may
be related to a primary decrease in filtration at the glomerulus.
The role of hydraulic permeability coefficient changes, with or
without renal hemodynamic alterations, in the reduction of
glomerular filtration in the current model was not studied.
There is definite evidence of tubular fluid back-leak, possibly
explaining the observation of a more marked decrease in total
animal GFR as compared to superficial SNGFR.
The site of "leak" appears to be a selectively damaged P3
segment of proximal tubule, beyond puncturable, physiological-
ly intact superficial, proximal tubule segments. In addition,
intratubular obstruction cannot be excluded and may contribute
to the decrease in the superficial SNGFR. The role of volume
depletion is minimal in the overall decrease of renal function.
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